ArticleJournal of addiction medicine2026
Innovations for Substance Use Disorders (I4SUD): Entrepreneurship Education to Help Substance Use Disorder Scientists Translate Ideas Into Effective Solutions.
Article in Journal of addiction medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesSubstance use disorders (SUDs) are a persistent health issue in the United States that demand interdisciplinary strategies. A major obstacle has been turning scientific innovations into successful commercial products. Our aim was to teach technology commercialization to a national group of SUD researchers, boosting their ability to develop and implement effective SUD solutions.
methodsWith the Office of Translational Initiatives and Program Innovations at the National Institute on Drug Abuse (NIDA), we created a 7-week program at Johns Hopkins Carey Business School called Innovations for SUD (I4SUD). Participants visited Baltimore for 3.5 days of in-person lectures, workshops, networking, and a visit to local SUD treatment centers. Online were 7 asynchronous modules (3-4 hours each), 3 1.5-hour synchronous sessions, and office hours. Each year, I4SUD ended with a 3-hour, 2-round "pitch" competition where one innovation received a $10,000 award. We report the evaluation of the first 3 cohorts.
resultsOut of 265 applicants, we enrolled 100 participants from 45 academic institutions from 2023 to 2025. Most had limited experience with basic technology commercialization concepts but improved significantly across 5 core learning objectives in pre- and post-assessments. Over 75% were motivated to seek additional funding at the program's conclusion. Participants rated highest the clinic site visits, workshops on defining unmet needs, office hours with NIDA and I4SUD experts, and pitch sessions.
conclusionsI4SUD provides a successful model of entrepreneurship education for SUD scientists that can be adapted to other settings, helping innovations reach the market and potentially impact people with SUDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.